Patent details

EP1771470 Title: ACTRII RECEPTOR POLYPEPTIDES, METHODS AND COMPOSITIONS

Basic Information

Publication number:
EP1771470
PCT Application Number:
PCT/US/2005/026368
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057754517
PCT Publication Number:
WO/2006/012627
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ACTRII RECEPTOR POLYPEPTIDES, METHODS AND COMPOSITIONS
French Title of Invention:
POLYPEPTIDES DU RECEPTEUR ACTRII, PROCEDES ET COMPOSITIONS CORRESPONDANTS
German Title of Invention:
ACTRII-REZEPTORPOLYPEPTIDE, VERFAHREN UND ZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
25/07/2005
Grant date:
26/06/2013
EP Publication Date:
26/06/2013
PCT Publication Date:
02/02/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/04/2007
EP B1 Publication Date:
26/06/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/07/2013
Expiration date:
25/07/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/09/2013
 
 

Name:
Acceleron Pharma Inc.
Address:
128 Sidney Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:
SEEHRA Jasbir
Address:
United States (US)

2

Name:
KNOPF John
Address:
United States (US)

Priority

Priority Number:
590765 P
Priority Date:
23/07/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 14/705;
Filing date Document type Number of pages